Multiple changes in sialic acid biology during human evolution - PubMed (original) (raw)

Review

Multiple changes in sialic acid biology during human evolution

Ajit Varki. Glycoconj J. 2009 Apr.

Abstract

Humans are genetically very similar to "great apes", (chimpanzees, bonobos, gorillas and orangutans), our closest evolutionary relatives. We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to sialic acids and in Siglecs (Sia-recognizing Ig superfamily lectins). An inactivating mutation in the CMAH gene eliminated human expression of N-glycolylneuraminic acid (Neu5Gc) a major sialic acid in "great apes". Additional human-specific changes have been found, affecting at least 10 of the <60 genes known to be involved in the biology of sialic acids. There are potential implications for unique features of humans, as well as for human susceptibility or resistance to disease. Additionally, metabolic incorporation of Neu5Gc from animal-derived materials occurs into biotherapeutic molecules and cellular preparations--and into human tissues from dietary sources, particularly red meat and milk products. As humans also have varying and sometime high levels of circulating anti-Neu5Gc antibodies, there are implications for biotechnology products, and for some human diseases associated with chronic inflammation.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Suggested scenario for multiple changes in sialic acid biology during human evolution. The initial loss of Neu5Gc expression during human evolution could have occurred randomly, or due to selection by a pathogen that preferentially recognized Neu5Gc on cell surfaces (e.g., a form of hominid malaria, or a bacterial toxin). Regardless of the reason, the resultant loss of Neu5Gc-binding sites for some CD33rSiglecs should have generated unusual immune activation, and further selection was likely required to allow adjustment for binding of Neu5Ac in some Siglecs, with elimination or loss of binding by others. Thus, all the other human specific changes in sialic acid biology discussed in the text could have resulted from adjustments to the original event of CMAH inactivation. Of course, other scenarios are possible. A non-genetic complexity is also indicated, in which dietary Neu5Gc can accumulate in human tissues in the face of an anti-Neu5Gc response, potentially facilitating diseases associated with chronic inflammation. (Modified from Varki A. Nature 446: 1023, 2007). Note that while CD33rSiglecs are shown as binding to sialic acids on the same cell surface, they can also potentially detect high densities of sialic acids on other cell surfaces or on Neu5Ac-expressing pathogens (which are common in humans)

Similar articles

Cited by

References

    1. Bishop J.R., Gagneux P. Evolution of carbohydrate antigens—microbial forces shaping host glycomes? Glycobiology. 2007;17:23R–34R. doi: 10.1093/glycob/cwm005. - DOI - PubMed
    1. Ohtsubo K., Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell. 2006;126:855–867. doi: 10.1016/j.cell.2006.08.019. - DOI - PubMed
    1. Varki A. Nothing in glycobiology makes sense, except in the light of evolution. Cell. 2006;126:841–845. doi: 10.1016/j.cell.2006.08.022. - DOI - PubMed
    1. Haltiwanger R.S., Lowe J.B. Role of glycosylation in development. Annu. Rev. Biochem. 2004;73:491–537. doi: 10.1146/annurev.biochem.73.011303.074043. - DOI - PubMed
    1. Freeze H.H. Genetic defects in the human glycome. Nat. Rev. Genet. 2006;7:537–551. doi: 10.1038/nrg1894. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources